CTRI/2020/11/029290已完成2 期
Concurrent chemoradiotherapy with carboplatin and capecitabine versus standard high dose cisplatin in locally advanced head and neck squamous cell cancer - CARCAP-H
Govt Kilpauk Medical College0 个研究点目标入组 81 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 81
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histopathologically confirmed cases of head and neck squamous cell cancer
- •2. Performance status: ECOG scale 0 to 2.
- •3. Normal hemogram: i.e Hb.10%, TLC >4000/cumm, platelet count >100,000/cu mm.
- •4. Creatinine clearance >50ml/min
排除标准
- •1. Patients not willing to participate in the study
- •2. Non squamous head and neck cancer
- •3. Uncontrolled diabetes, hypertension, acute or chronic kidney disease, congestive cardiac failure
- •4. HIV, HBV, HCV reactive disease
- •5. Concomitant administration of other experimental drugs
- •6. Previous radiotherapy to head and neck region
研究者
相似试验
已完成
不适用
Concurrent Chemoradiotherapy with Cisplatin and Docetaxel for Advanced Head and Neck Cancer Phase II StudyHead and neck squamous cell carcinoma at stage III and IVJPRN-C000000273Department of Otolaryngology, Osaka University School of Medicine160
已完成
不适用
The combination chemotherapy of carboplatin and TS-1 followed by the maintenance therapy of TS-1 in advanced non-small cell lung cancer. Phase 2 trial.JPRN-UMIN000025932niversity of Fukui25
进行中（未招募）
不适用
Radiotherapy and chemotherapy with cisplatin and temozolomide for patients affected by primary glioblastoma of new diagnosis - NDPrimary GLIOBLASTOMA of first diagnosisMedDRA version: 9.1Level: PTClassification code 10018336MedDRA version: 9.1Level: SOCClassification code 10029205EUCTR2008-000380-42-ITISTITUTO NEUROLOGICO CARLO BESTA
招募中
Unknown
Rechallenge chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel for patients with non-small-cell lung cancer and interstitial lung diseasePatients with non-small-cell lung cancer and interstitial lung diseaseJPRN-UMIN000050630Chiba University Hospital24
已完成
不适用
Study of alternating chemoradiotherapy combined with proton beam therapy and intra-arterial infusion chemotherapy for advanced tongue cancerlocally advenced tongue cancerJPRN-UMIN000032732Department of radiation oncology, Southern Tohoku Proton Therapy Center30